Back
Ingersoll Rand Vs. Kymera Therapeutics Industry Stock Comparison
Buy
66
IR
Ingersoll Rand
Last Price:
93.12
Seasonality Move:
0.64%
Sell
39
KYMR
Kymera Therapeutics
Last Price:
32.10
Seasonality Move:
34.28%
Buy
66
Ingersoll Rand (IR)
is a Buy
Is Ingersoll Rand a Buy, Sell or Hold?
- The current Ingersoll Rand [IR] share price is $92.00. The Score for IR is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- IR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Kymera Therapeutics (KYMR)
is a Sell
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $32.16. The Score for KYMR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- KYMR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IR Stock Price Chart
What is Ingersoll Rand's stock price today?
-
The Ingersoll Rand share price today is $92.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IR is experiencing buying pressure, which is a positive indicator for future bullish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $32.16
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYMR is experiencing slight selling pressure.
IR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.5 | Buy |
Relative Strength Index (14 RSI): | 48.31 | Sell |
Chaikin Money Flow: | 1474742 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (90.2 - 94.46) | Sell |
Bollinger Bands (100): | (83.24 - 94.32) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.93 | Sell |
Relative Strength Index (14 RSI): | 34.62 | Sell |
Chaikin Money Flow: | -115350 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.64 - 37.56) | Sell |
Bollinger Bands (100): | (31.9 - 40.4) | Sell |
IR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 94.1 | Sell |
20-day SMA: | 92.15 | Sell |
50-day SMA: | 92.48 | Sell |
200-day SMA: | 78.49 | Buy |
8-day EMA: | 93.12 | Sell |
20-day EMA: | 92.74 | Sell |
50-day EMA: | 91.52 | Buy |
200-day EMA: | 80.85 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.18 | Sell |
20-day SMA: | 35.94 | Sell |
50-day SMA: | 36.33 | Sell |
200-day SMA: | 27.28 | Buy |
8-day EMA: | 33.83 | Sell |
20-day EMA: | 35.01 | Sell |
50-day EMA: | 35.76 | Sell |
200-day EMA: | 31.14 | Buy |
Ingersoll Rand Earnings Growth & IR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $0.04 per share, an increase this year of $0.41 per share, and an increase next year of $0.31 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.07 per share, a decrease this year of $0.09 per share, and a decrease next year of $0.31 per share.
Ingersoll Rand Technical Analysis
May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |